Toll Free: 1-888-928-9744

Senhwa Biosciences, Inc. - Product Pipeline Review - 2014

Published: Jun, 2014 | Pages: 28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Senhwa Biosciences, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Senhwa Biosciences - Product Pipeline Review - 2014', provides an overview of the Senhwa Biosciences's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Senhwa Biosciences's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Senhwa Biosciences including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Senhwa Biosciences's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Senhwa Biosciences's pipeline products

Reasons to buy

- Evaluate Senhwa Biosciences's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Senhwa Biosciences in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Senhwa Biosciences's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Senhwa Biosciences and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Senhwa Biosciences
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Senhwa Biosciences and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Senhwa Biosciences, Inc. Snapshot 4
Senhwa Biosciences, Inc. Overview 4
Key Information 4
Key Facts 4
Senhwa Biosciences, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Senhwa Biosciences, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Senhwa Biosciences, Inc. - Pipeline Products Glance 10
Senhwa Biosciences, Inc. - Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
Senhwa Biosciences, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Senhwa Biosciences, Inc. - Drug Profiles 12
silmitasertib 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
CX-5461 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
CK2 Inhibitor Program 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
P53/RNA Polymerase I Program 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Senhwa Biosciences, Inc. - Pipeline Analysis 18
Senhwa Biosciences, Inc. - Pipeline Products by Target 18
Senhwa Biosciences, Inc. - Pipeline Products by Route of Administration 19
Senhwa Biosciences, Inc. - Pipeline Products by Molecule Type 20
Senhwa Biosciences, Inc. - Pipeline Products by Mechanism of Action 21
Senhwa Biosciences, Inc. - Recent Pipeline Updates 22
Senhwa Biosciences, Inc. - Dormant Projects 25
Senhwa Biosciences, Inc. - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28
List of Tables
Senhwa Biosciences, Inc., Key Information 4
Senhwa Biosciences, Inc., Key Facts 4
Senhwa Biosciences, Inc. - Pipeline by Indication, 2014 7
Senhwa Biosciences, Inc. - Pipeline by Stage of Development, 2014 8
Senhwa Biosciences, Inc. - Monotherapy Products in Pipeline, 2014 9
Senhwa Biosciences, Inc. - Phase I, 2014 10
Senhwa Biosciences, Inc. - Preclinical, 2014 11
Senhwa Biosciences, Inc. - Pipeline by Target, 2014 18
Senhwa Biosciences, Inc. - Pipeline by Route of Administration, 2014 19
Senhwa Biosciences, Inc. - Pipeline by Molecule Type, 2014 20
Senhwa Biosciences, Inc. - Pipeline Products by Mechanism of Action, 2014 21
Senhwa Biosciences, Inc. - Recent Pipeline Updates, 2014 22
Senhwa Biosciences, Inc. - Dormant Developmental Projects,2014 25
Senhwa Biosciences, Inc., Other Locations 26 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify